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Objective: Conventional harvesting of saphenous vein used for coronary artery bypass surgery induces a vaso-
spasm that is overcome by high-pressure distension. Saphenous vein harvested with its cushion of perivascular
tissue by a ‘‘no touch’’ technique does not undergo vasospasm and distension is not required, leading to an im-
proved graft patency. The aim of this study is to investigate the effect of surgical damage and high-pressure dis-
tension on endothelial integrity and endothelial nitric oxide synthase expression and activity in saphenous vein
harvested with and without perivascular tissue.
Methods: Saphenous veins from patients (n ¼ 26) undergoing coronary artery bypass surgery were prepared
with and without perivascular tissue. We analyzed the effect of 300 mm Hg distension on morphology and en-
dothelial nitric oxide synthase/nitric oxide synthase activity using a combination of immunohistochemistry,
Western blot analysis, reverse transcriptase polymerase chain reaction, and enzyme assay in distended (with
and without perivascular tissue) compared with nondistended (with and without perivascular tissue) segments.
Results:Distension induced substantial damage to the luminal endothelium (assessed by CD31 staining) and ves-
sel wall. Endothelial nitric oxide synthase expression and activity were significantly reduced by high-pressure
distension and removal of, or damage to, perivascular tissue. The effect of distension was significantly less for
those with perivascular tissue than for those without perivascular tissue in most cases.
Conclusion: The success of the saphenous vein used as a bypass graft is affected by surgical trauma and disten-
sion. Veins removed with minimal damage exhibit increased patency rates. We show that retention of perivascular
tissue on saphenous vein prepared for coronary artery bypass surgery by the ‘‘no touch’’ technique protects
against distension-induced damage, preserves vessel morphology, and maintains endothelial nitric oxide
synthase/nitric oxide synthase activity.The long saphenous vein (SV) is the most commonly used
conduit for coronary artery bypass grafting (CABG) since
its introduction in 1969.1 However, the occlusion rate of
this vessel is high, with 15% to 30% of grafts failing during
the first year and more than 50% of patients requiring
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doi:10.1016/j.jtcvs.2008.11.060334 The Journal of Thoracic and Cardiovascular Suregrafting within 10 years.2,3 The precise mechanisms
involved in graft failure remain unclear, although surgical
trauma to the SV and the effects after implantation into the
arterial circulation are important. During conventional
CABG surgery, the fascial canal surrounding the vein,
formed predominantly by adipose tissue,4 is opened longitu-
dinally and the vein’s outermost layer, the adventitia is dam-
aged, leading to SV vasospasm.5 High distension pressures
used to overcome vasospasm and check for leaks before
graft implantation5 induce substantial damage to the vein
when observed at the ultrastructural level.6 Endothelial cells
appear deformed, flattened, and polymorphic, and contain an
abundance of cytoplasmic vesicles. In addition, exposure of
subendothelial connective tissue and occasional platelet and
fibrin attachment to the intima was observed. Moreover, ad-
ventitial damage was represented by a reduced number of
vasa vasorum.6
In 1996 Souza7 described a ‘‘no touch’’ (NT) technique of
CABG in which the SV is harvested complete with the sur-
rounding fascial canal. Patients receiving NT SV graftsrgery c August 2009
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CABG ¼ coronary artery bypass grafting
DIST ¼ distended
eNOS ¼ endothelial nitric oxide synthase
NDIST ¼ nondistended
NOS ¼ nitric oxide synthase
NT ¼ ‘‘no touch’’
PCR ¼ polymerase chain reaction
PVT ¼ perivascular tissue
SV ¼ saphenous vein
VSMC ¼ vascular smooth muscle cell
show improved early- and long-term graft patency compared
with patients undergoing conventional CABG.8,9 Although
the mechanisms underlying the advantages of the NT tech-
nique have not been fully elucidated, the need to reduce vas-
cular damage during harvesting and the benefits of the NT
technique have been recognized.10-14 Furthermore, the pres-
ence of perivascular adipose tissue might have additional
benefits for the graft. First, perivascular adipose tissue of
human internal thoracic arteries has been shown to release
a vasodilatory factor that might reduce vasospasm of graft
vessels.15 Moreover, perivascular adipose tissue reduces
the sensitivity to vasoconstrictor agents and increases the
responses to some vasodilatory agents depending on tangen-
tial stress.16
These findings led us to hypothesize that perivascular tis-
sue (PVT) surrounding NT veins protects the vein against
high pressures, as occurs after implantation into the arterial
circulation. Therefore, the aim of this study was to investi-
gate possible mechanisms by which the PVT affects disten-
sion-induced damage and endothelial nitric oxide synthase
(eNOS) expression and activity of SVs harvested by the con-
ventional and NT techniques from patients undergoing
CABG surgery.
MATERIALS AND METHODS
Saphenous Vein Harvesting and High-Pressure
Distension
The investigation conforms with the principles outlined in the Declaration
of Helsinki. Under local ethics committee approval and patients’ informed
consent, segments of SV were harvested from 26 patients undergoing
CABG at the Department of Thoracic and Cardiovascular Surgery, O¨rebro
University Hospital, Sweden (3 female, age 40–69 years; 23 male, age 43–
79 years). All patients were hypertensive and receiving antihypertensives,
statins, and aspirin. From each patient, 1 segment of the SV was harvested
conventionally, where the vessel was stripped of its cushion of PVT and dis-
tended with saline at a pressure of 300 mm Hg (measured on a manometer)
for 1 minute (PVT/DIST). Another segment was also stripped of surround-
ing tissue, but not distended (PVT/NDIST). NT vein segments were pre-
pared atraumatically. The SV was removed complete with its cushion of
perivascular tissue, and these segments were not distended (þPVT/NDIST;
for description of original technique, refer to Vasilakis and colleagues6
and Souza7). An additional group was included for whom the SV was re-The Journal of Thoracic andmoved with its surrounding tissue and distended at 300 mm Hg for 1 minute
(þPVT/DIST). Samples were then prepared for appropriate processing.
Histology
Vein segments from 5 patients were formalin fixed and embedded in
paraffin. Transverse 4-mm sections from each of the 4 vein samples
(PVT/DIST,PVT/NDIST,þPVT/DIST,þPVT/NDIST) were cut, sequen-
tially mounted onto microscope slides, and stored at room temperature until
ready for processing. Sections were dewaxed, hydrated, and transferred into
distilled water. Standard elastic van Gieson staining was performed on
slides containing 2 sections of each of the 4 vein segments.
Measurement of Medial Thickness
Medial thickness was measured at 4 opposite sites of each elastic
van Gieson-stained vein section (PVT/DIST, PVT/NDIST, þPVT/
DIST, þPVT/NDIST) on 2 sections per slide from 5 patients. Measure-
ments were taken from the internal to the external elastic lamina at 340
magnification (Figure 1). Distance was calculated by converting the
number of pixels to micrometers using a stage micrometer on captured
images.
Cellular Localization of CD31 and eNOS by
Immunohistochemistry
For immunohistochemistry, antigens were unmasked by microwaving
the sections in 10 mmol/L sodium citrate buffer for 5 minutes, and standard
immunohistochemistry was performed as described previously using the
avidin-biotin complex alkaline phosphatase method (Vector Laboratories,
Peterborough, UK).17 CD31 antibody was used for determination of endo-
thelial integrity, and nerves were identified using NF200 (Dako Ltd,
Glostrup, Denmark). eNOS was identified using a polyclonal anti-eNOS
antibody (Santa Cruz Biotechnology, Autogen Bioclear Ltd, Calne, UK).
Sections were lightly counterstained with Mayer’s hematoxylin, examined
by microscope, and photographed digitally, and images were stored via
a KS300 imaging system (Imaging Associates, Bicester, UK).
Western Blotting for CD31 and eNOS
Segments harvested from another group of 8 patients were frozen in
liquid nitrogen at surgery (within 10 minutes of removal) and stored at
–70C until use. Western blots were prepared as described previously,17
where rabbit anti-eNOS (Santa Cruz Biotechnology) and monoclonal
anti-CD31 (Dako Ltd) antibodies were used. Protein concentration
was determined by the Bradford assay, and resultant antigen-antibody
complexes were detected by incubation with avidin-biotin complex
reagent (Vector) using the enhanced chemiluminescence substrate kit
(Amersham Biosciences, Buckinghamshire, UK). Films were analyzed
by scanning densitometry on an Ultroscan XL (LKB Wallac, Cam-
bridge, UK) with correction of densitometric units according to the ß-
actin signal, as a surrogate for cell number. eNOS protein in the
adventitia was also examined by carefully dissecting this layer in the
laboratory from additional NT vein segments from 5 patients and com-
paring adventitial/vein eNOS protein levels.
Determination of eNOS mRNA Expression
Real-time quantitative polymerase chain reaction (PCR) was used as pre-
viously described18 on RNA isolated from vein segments from 9 patients.
Each sample was treated with DNAase (1 U/mg RNA) and RQ1 RNAase-
free DNAase (Promega, Wis), and then reverse transcribed into cDNA using
random hexamer primers (Roche, Mannheim, Germany) and Moloney
murine leukemia virus reverse transcriptase (Life Technologies Inc, Paris,
France). Real-time quantitative PCR was performed using the ABI Prism
7700 Sequence Detection System (Perkin-Elmer Applied Biosystems,
Foster City, Calif). 18S mRNA standard (Applied Biosystems) was used as
the endogenous control. Human eNOS was amplified using the followingCardiovascular Surgery c Volume 138, Number 2 335
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Acquired Cardiovascular Disease Dashwood et alFIGURE 1. Transverse elastic van Gieson-stained SV sections comparing NDIST PVT removed (PVT, A), intact (þPVT, C), and DIST segments with (D)
and without PVT (B). The bars indicate points of media measurement. The lumen of NDIST segments was thrown into folds. Scale bar¼ 1 mm. See tables for
quantitative data and statistical analysis. M, Media; DIST, distended; NDIST, nondistended; PVT, perivascular tissue.primers: forward primer 5’GAG ATG TCC GGC CCC TAC A 3’ and re-
verse primer 5’CCC AAA CTC TCA CCC AAC TCA 3’. The 5’end
FAM-labeled Taqman probe for eNOS was TCC CCT CGG CCG GAA
CAG C 3’. eNOS expression was normalized to the endogenous control,
18S mRNA, and the amount of eNOS mRNA in each sample expressed
relative to that in the control from each patient.
Determination of eNOS Activity by the Citrulline
Assay
Tissue lysates were prepared from approximately 5-mm lengths of vein
from 6 patients as described above. Total nitric oxide synthase (NOS) activ-
ity was determined by the conversion of [14C]-arginine to [14C]-citrulline
using a NOS activity assay kit (Calbiochem, Nottingham, UK) and
expressed in femtomole/minutes/milligram of protein, determined by the
bicinchonic acid protein assay (Pierce, Ill).17
Statistical Analyses
Data are expressed as mean and standard deviation (Table 1). Differ-
ences between the samples collected with the different techniques (PVT
and distension) were analyzed in mixed model analyses where the correla-
tion between samples taken from the same patient could be taken into ac-
count. The technical specification of the analysis was a correlation336 The Journal of Thoracic and Cardiovascular Sustructure with compound symmetry, and the degrees of freedom were given
by the Satterthwaite method. Two specific analyses were performed. The
first concerned the conventional technique (PVT/DIST) versus the NT
technique (þPVT/NDIST). In the second analysis, the 2 factors that distin-
guish the NT technique from the conventional technique were in focus,
that is, PVT ( orþ) and DIST (yes or no), and the interaction of these 2
factors. Statistical analysis was performed using SAS software, version
9.1.3 (SAS Institute Inc, Cary, NC).
RESULTS
General Vessel Morphology
The lumen of nondistended SV segments, with removed
(PVT/NDIST; Figure 1, A) or intact perivascular tissue
(þPVT/NDIST; Figure 1, C), was barely visible because
the intima was thrown into folds. High-pressure distension
had a marked effect on morphology, as seen in the transverse
plane. The intimal folds of distended segments were absent
or considerably reduced in both –PVT/DIST (Figure 1, B)
andþPVT/DIST (Figure 1, D) veins. The mean value for
the conventional method is different from NT (P ¼ .022,TABLE 1. Mean values and standard deviations for five effect measures
Measure PVT/DIST (conventional) PVT/NDIST þPVT/DIST þPVT/NDIST (NT)
P value for
conventional versus NT
Wall thickness (n ¼ 5) 278.8 (57.6) 655.4 (153.9) 439.2 (156.8) 673.2 (272.0) .022
CD31 Western blots (n ¼ 5) 4.66 (2.51) 7.50 (2.47) 7.54 (2.17) 8.38 (2.52) .0009
Western blot for eNOS (n ¼ 8) 2.65 (0.74) 4.25 (2.27) 12.98 (4.59) 13.30 (3.93) <.0001
Citrulline assay (n ¼ 6) 0.45 (0.33) 1.40 (0.89) 2.85 (0.95) 3.48 (0.62) <.0001
eNOS mRNA (DCT) (n ¼ 9) 6.68 (3.82) 8.16 (4.47) 9.70 (3.92) 7.93 (2.38) .40
PVT, Perivascular tissue; DIST, distended; NDIST, nondistended. Statistical significance (P values) for the difference between conventional and NT is shown.rgery c August 2009
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icant factor (P<.0001) and not the PVT factor (P ¼ .13). It
is, however, also seen that distension is more harmful to
–PVT than toþPVT (difference due to distension is376.6
for –PVT, 234 for þPVT), although not quite reaching
statistical significance.
Endothelial Integrity Determined by CD31 and
eNOS Immunostaining
The effect of high-pressure distension on the luminal en-
dothelium, determined by CD31 staining, was observed at
high magnification only in the absence of PVT. In –PVT/
DIST veins, there were large regions of endothelial denuda-
tion with only few remaining endothelial cells (Figure 2).
However, inþPVT veins, endothelial cells formed an almost
TABLE 2. Statistical significance (P values) for differences in
perivascular tissue, distension, and their interaction
PVT (±) DIST (yes/no) Interaction
Measure P valuea P valueb P valuea,b
Wall thickness (n ¼ 5) .13 <.0001 NS
CD31 Western blots (n ¼ 5) .0001 .0001 .01
Western blot for eNOS (n ¼ 8) <.0001 .27 NS
Citrulline assay (n ¼ 6) <.0001 .009 NS
eNOS mRNA (DCT) (n ¼ 9) .29 .89 NS
PVT, Perivascular tissue; DIST, distended; eNOS, endothelial nitric oxide synthase;
NS, not significant. aP value from a mixed model analysis for test of PVT (),
DIST (yes/no), and the interaction PVT*DIST. bIf interaction is not significant, results
are those with no interaction factor included in the model.The Journal of Thoracic and Ccontinuous lining of the intimal layer (Figure 2). This was
also observed in –PVT/NDIST vein segments (Figure 2).
Western blot analysis showed that CD31 protein was signif-
icantly lower in the conventional group (–PVT/DIST) versus
the NT group (Figure 3, Table 1, P ¼ .0009). A significant
interaction between the PVT factor and the DIST factor is
seen because the difference between DIST and NDIST for
–PVT is large compared with the corresponding difference
forþPVT (Table 2, P¼ .01 for interaction). Thus, distension
is more harmful to –PVT (difference due to distension is
–2.84) than toþPVT (difference due to distension –0.84).
Immunostaining for eNOS in –PVT/DIST segments was
absent at areas of endothelial denudation (Figure 2, B). In
contrast, the endothelium of nondistended veins exhibited
a continuous eNOS immunostaining both in the absence
(PVT/NDIST, Figure 2, A) and presence (þPVT/NDIST,
Figure 2, C) of PVT. Moreover, eNOS immunostaining
was also unaffected by distension inþPVT/DIST segments
(Figure 2, D).
Adventitial Integrity and eNOS Immunostaining
As shown in Figure 4, the adventitial layer contains a
network of nourishing microvessels, the vasa vasorum, and
nerves. This layer remained intact inþPVT vein segments
and exhibited positive eNOS immunoreactivity, much of
which was associated with the endothelium of the vasa vaso-
rum and the vascular nerves (Figure 4). In addition, there was
dense staining of neighboring adventitial cells, composedFIGURE 2. Examples of SV stained with anti-eNOS. Luminal eNOS in –PVT/DIST (conventional) vein (B) is interrupted with positive staining at regions
where the endothelium is intact (arrow). Endothelial denudation is caused by high-pressure distension. In all other SV segments (A, C, and D), eNOS
immunostaining is continuous. Scale bar ¼ 0.1 mm. PVT, Perivascular tissue.ardiovascular Surgery c Volume 138, Number 2 337
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blasts, and collagen (Figure 4). These regions of eNOS im-
munostaining were absent in segments of –PVT/DIST and
–PVT/NDIST veins, where the surrounding tissue, including
the adventitia, was removed or damaged.
eNOS mRNA and Protein Expression
To quantify eNOS expression, real-time reverse transcrip-
tase PCR was performed. Of the 3 NOS isoforms, eNOS
mRNA levels were highest in the SV (our unpublished
FIGURE 3. Top panels, representative photomicrographs of eNOS immu-
nostaining of SV segments. The effect of distension on the endothelium is
greater in –PVT/DIST (conventional) segments, where only few endothelial
cells remain (arrow). InþPVT or NDIST segments, the endothelium re-
mains intact (see Figure 2). Representative Western blots for CD31 (endo-
thelial cells) and eNOS are shown with b actin control. See tables for
quantitative data and statistical analysis. eNOS, Endothelial nitric oxide syn-
thase; PVT, perivascular tissue; NDIST, nondistended; DIST, distended.338 The Journal of Thoracic and Cardiovascular Sudata; S. G. Shaw, DPhil, November 5, 2002). There were
no significant differences between groups in cycle times rel-
ative to 18S mRNA (DCT) (PVT/DIST¼ 6.7 3.8;PVT/
NDIST ¼ 8.2  4.5; þPVT/NDIST ¼ 7.9  2.4; þPVT/
DIST ¼ 9.7  3.9).
Western blot analysis showed a significant difference
between –PVT/DIST and þPVT/NDIST (P< .0001, Ta-
ble 1; Figure 3), and the difference is basically depen-
dent on the PVT factor (Table 2, P < .0001) and not
the DIST factor (Table 2, P ¼ .27). However, the differ-
ence due to distension was higher for –PVT than for
þPVT (1.60 vs –0.32, although not reaching statistical
significance). Because þPVT/NDIST segments exhibited
significantly higher eNOS protein levels than both
–PVT/DIST and -PVT/NDIST segments, the perivascular
cushion was separated from NT segments in 5 further
cases. This layer expressed 34%  5% (mean  stan-
dard error of the mean, n ¼ 5) more eNOS protein
than the SV segments from which they had been re-
moved (P< .05, data not shown).
NOS Activity
NOS activity was determined using the citrulline assay.
According to the higher eNOS protein expression described
in the perivascular surrounding cushion, þPVT segments
exhibited a higher eNOS activity than –PVT segments
(Table 1, P< .0001). The effect of distension on NOS
activity was also significant (Table 2, P ¼ .009) and not
dependent on the presence of PVT (Table 2, interactionFIGURE 4. eNOS immunostaining of the vasa vasorum (CD31) and vascular nerves (NF200) within the adventitia of aþPVT/NDIST segment (arrows). The
surrounding VSMCs, fibroblasts, and collagen also exhibit eNOS immunoreactivity. A negative control is shown (VE). Dotted lines indicate the external
elastic lamina separating the tunica media and adventitia . Scale bar¼ 0.05 mm. eNOS, Endothelial nitric oxide synthase; TM, tunica media; ADV, adventitia.rgery c August 2009
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in –PVT/DIST compared with –PVT/NDIST (Table 1,
P< .0001). However, there were no significant differences
betweenþPVT/DIST andþPVT/NDIST segments.
DISCUSSION
In this study we show that surgical trauma caused by re-
moval of PVT and high-pressure distension using conven-
tional harvesting techniques damages the integrity of the
endothelium and the adventitia in SVs used for CABG sur-
gery, leading to a reduction in eNOS protein and eNOS activ-
ity. The distension-induced damage is attenuated in veins
surrounded by PVT, suggesting that there is a ‘‘protective’’
action of the vein’s surrounding cushion that may be main-
tained once the NT vein is placed under arterial pressure at
completion of graft implantation. Also, high-pressure disten-
sion substantially alters vein morphology and affects all 3
vein layers. The luminal folds and endothelial integrity of
NT vein segments is preserved, whereas endothelial denuda-
tion occurs in conventionally harvested SVs that are distended
and stripped of their perivascular cushion.12 The integrity of
the luminal endothelium of distended NT veins (þPVT/
DIST) is preserved, confirming that the PVT reduces endothe-
lial damage caused by saline distension in these segments.
Vascular damage and high-pressure distension also
correlate with a reduction in eNOS immunostaining,
eNOS protein levels, and eNOS activity. The use of real-
time reverse transcriptase PCR showed no effect on expres-
sion of eNOS mRNA and no significant difference between
all SV segments studied (Tables 1 and 2, P>.05). Although
up-regulation of immediate-early c-fos and c-myc genes oc-
curs within 1 hour of SV harvesting,19 our results suggest
that the effect on tissue eNOS protein and activity, at least
in the short term, does not involve transcriptional regulation.
Segments with PVT exhibited significantly higher levels of
eNOS protein and activity than stripped segments and were
almost unaffected by high-pressure distension. This is
because a considerable proportion of the vein’s eNOS is
associated with the adventitia and potential nitric oxide-
producing structures, such as the vasa vasorum and vascular
nerves. Because the adventitia is damaged during conven-
tional CABG, we propose that injury of this layer contributes
to graft failure and that its preservation plays an important
role in the success of the NT technique.14,20,21 The vasa
vasorum nourishes both perivascular nerves and adipose
tissue22 and provides the media with oxygen and nutrients.23
Disruption of the vasa vasorum results in abnormal mor-
phology of VSMCs and stiffening of the outer media, thus
reducing the vessel’s vasodilator capacity.24 Furthermore,
occlusion or severing of these microvessels leads to medial
ischaemia and subsequent neointimal hyperplasia.25 Al-
though the vasa vasorum of NT veins is ‘‘disconnected’’
at harvesting, blood supply to the vessel wall will be restored
because retrograde blood flow has been observed on re-The Journal of Thoracic andmoval of vascular clamps at completion of anastomosis.9
The benefits of maintaining the graft’s endogenous eNOS
activity and NO production may be highly relevant for the
prevention of vein graft occlusion because it has been shown
that adventitial liposomal transfection of eNOS gene reduces
vein graft failure26 and adenoviral eNOS transfection in-
hibits the migration and proliferation of VSMCs and platelet
adhesion in human SV tissue.27
CONCLUSIONS
One interesting finding of this study is that preserving the
external perivascular cushion of the vein reduces histologic
signs of tissue damage and the effect of distension on endo-
thelial and adventitial integrity at the time of vein harvesting.
In addition to endothelial loss, placement of SV grafts into
high-pressure conditions induces a number of early changes
in the expression of genes stimulating VSMC proliferation19
and phosphorylation of p38-MAPK, a factor involved in
graft occlusion.28 Therefore, we stress the importance of
the PVT acting as a buffer and protecting the vein against ar-
terial pressures at completion of graft implantation, with the
luminal endothelium and adventitia remaining intact postop-
eratively. In this regard, several artificial manipulations,
such as perivascular application of fibrin glue29 or placement
of an external stent,30 have been demonstrated to reduce cir-
cumferential vein stretching at arterial pressures. Also, NOS
levels and activity increase in the adventitia of stented grafts
compared with unstented grafts.31 Moreover, the presence of
perivascular adipose tissue, which modulates vascular func-
tion in several experimental models and various blood ves-
sels,15,16,32-36 may have additional benefits on graft patency.
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